Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
Clinical trial NCT02046148 · COMPLETED
Trial details
- NCT number
- NCT02046148
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-18
- Primary completion
- 2015-12-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.